Prof. Dr. NİLGÜN SAYINALP

1. Transcriptome Analysis of Beta-Catenin-Related Genes in CD34+ Haematopoietic Stem and Progenitor Cells from Patients with AML

Gunes B. A., Ozkan T., Gurel A. K., Dalkilic S., Belder N., Ozkeserli Z., et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.16, sa.1, 2024 (SCI-Expanded, Scopus)

2. Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations

ÜMİT E. G., DEMİR A. M., AR M. C., Ayer M., Ayli M., Karakus V., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.41, sa.3, ss.141-145, 2024 (SCI-Expanded, Scopus, TRDizin)

3. The effect of prognostic features of patients with chronic lymphocytic leukemia on overall survival and treatment-free survival: A single-center experience

Alayvaz Aslan N., BÜYÜKAŞIK Y., SAYINALP N.

Journal of Experimental and Clinical Medicine (Turkey) , cilt.41, sa.1, ss.125-131, 2024 (Scopus)

4. Four‑Dimensional Echocardiographic Evaluation of Cardiac Iron Overload in Patients with Beta-Thalassemia Major

FEDAİ A. B., KARAKULAK U. N., Aladag E., SAYINALP N.

Cardiovascular Toxicology , cilt.24, sa.1, ss.41-48, 2024 (SCI-Expanded, Scopus)

5. Management of Adult Primary Immune Thrombocytopenia: DelphiBased Consensus Recommendations

DEMİR A. M., ÜMİT E. G., AR M. C., Ayer M., Ayli M., Karakus V., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.41, sa.2, ss.97-104, 2024 (SCI-Expanded, Scopus, TRDizin)

6. A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients

MEHTAP Ö., TOPTAŞ T., Dal M. S., KEKLİK KARADAĞ F., Atas U., ÖZSAN G. H., et al.

LEUKEMIA & LYMPHOMA , cilt.65, ss.2190-2198, 2024 (SCI-Expanded, Scopus)

7. History Of The Hematology Proficiency Exam And The Turkish Experience

BULDUK T., Demir A. M., Andic N., Sayınalp N., aylı m.

STED/Sürekli Tıp Eğitimi Dergisi , cilt.32, sa.4, ss.281-291, 2023 (TRDizin)

8. Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives

AR M. C., El Fakih R., Gabbassova S., Alhuraiji A., Nasr F., Alsaeed A., et al.

Leukemia Research , cilt.133, 2023 (SCI-Expanded, Scopus)

9. Endocrine Disorders in Adult Beta-Thalassemia Patients: Insights from a Long-Term Follow-Up

Oğuz S. H., OKAY M., FEDAİ A. B., ÜNAL Ş., GÜMRÜK F., SAYINALP N., et al.

Endocrinology Research and Practice , cilt.27, sa.4, ss.205-212, 2023 (Scopus, TRDizin)

10. A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)

11. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)

12. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

13. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin)

14. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded, Scopus)

15. Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded, Scopus, TRDizin)

16. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.

Transfusion and Apheresis Science , cilt.59, sa.5, 2020 (SCI-Expanded, Scopus)

17. Indications and outcomes of splenectomy for hematological disorders

Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.

OPEN MEDICINE , cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded, Scopus)

18. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Chanan-Khan A., Cramer P., Demirkan F., Fraser G., Silva R. S., Grosicki S., et al.

LANCET ONCOLOGY , cilt.17, sa.2, ss.200-211, 2016 (SCI-Expanded, Scopus)

19. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin)

20. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia

ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.

HEMATOLOGY , cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded, Scopus)

21. Clinical and pathological correlations of marrow PUMA and P53 expressions in myelodysplastic syndromes.

Bektas O., Uner A., Buyukasik Y., Uz B., Bozkurt S., Eliacik E., et al.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , cilt.123, ss.445-51, 2015 (SCI-Expanded, Scopus)

22. The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)

23. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded, Scopus, TRDizin)

24. Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)

25. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.

ACTA HAEMATOLOGICA , cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus)

26. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)

27. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Increased Soluble Selectins as a Reflection of Activated Platelets and Endothelium in Legg-Calve-Perthes Disease

Ismayilov V., Aksoy D. Y., SAYINALP N., Haznedarog I. C., AKSOY M. C.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.36, sa.7, 2014 (SCI-Expanded, Scopus)

29. Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded, Scopus, TRDizin)

30. Clinical Perspectives About the Molecular Management of B-Lymphoproliferative Neoplasms

HAZNEDAROĞLU İ. C., SAYINALP N.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.1-3, 2014 (SCI-Expanded, Scopus, TRDizin)

31. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded, Scopus, TRDizin)

32. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded, Scopus, TRDizin)

33. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.

HEMATOLOGY , cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded, Scopus)

34. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded, Scopus, TRDizin)

35. Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis

Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded, Scopus)

36. Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis

Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded, Scopus, TRDizin)

37. Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded, Scopus, TRDizin)

38. Nasal Natural Killer/T-cell Lymphoma with Skin, Eye, and Peroneal Nerve Involvement

Turker B., Uz B., Isik M., BEKTAŞ Ö., DEMİROĞLU H., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.29, sa.4, ss.413-419, 2012 (SCI-Expanded, Scopus, TRDizin)

39. Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL

Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded, Scopus, TRDizin)

40. Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML

AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded, Scopus, TRDizin)

41. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria

GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.3, ss.223-227, 2011 (SCI-Expanded, Scopus, TRDizin)

42. THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.74, sa.1, ss.7-12, 2011 (ESCI, TRDizin)

43. Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES , cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded, Scopus)

44. A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia

Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.20, sa.4, ss.341-344, 2011 (SCI-Expanded, Scopus)

45. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.

LEUKEMIA RESEARCH , cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)

46. DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.73, sa.3, ss.74-79, 2010 (ESCI, TRDizin)

47. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded, Scopus, TRDizin)

48. Spinal Myeloid Sarcoma in Two Non-Leukemic Patients

Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

INTERNAL MEDICINE , cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded, Scopus)

49. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded, Scopus, TRDizin)

50. Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.

MEDICAL ONCOLOGY , cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded, Scopus)

51. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.

ANNALS OF HEMATOLOGY , cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded, Scopus)

52. Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.101, sa.4, ss.370-372, 2009 (SCI-Expanded, Scopus)

53. The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey

Ozatli D., GÖKER H., Buyuhasik Y., Sayinalp N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.29, sa.2, ss.388-394, 2009 (SCI-Expanded, Scopus)

54. Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.101, sa.3, ss.270-272, 2009 (SCI-Expanded, Scopus)

55. Thrombomodulin and GFC levels in Legg-Calve-Perthes disease

AKSOY M. C., Aksoy D. Y., HAZNEDAROĞLU İ. C., Sayinalp N., Kirazli S., Alpaslan M.

HEMATOLOGY , cilt.13, sa.6, ss.324-328, 2008 (SCI-Expanded, Scopus)

56. Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.

ANNALS OF HEMATOLOGY , cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded, Scopus)

57. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients

BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.19, sa.7, ss.633-637, 2008 (SCI-Expanded, Scopus)

58. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts

Koca E., BÜYÜKAŞIK Y., Cetiner D., Yimaz R., Sayinalp N., Yasavul U., et al.

LEUKEMIA RESEARCH , cilt.32, sa.3, ss.495-499, 2008 (SCI-Expanded, Scopus)

59. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded, Scopus)

60. Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease

Koca E., Haznedaroglu I. C., ÜNER A., Sayinalp N., Saglam A. E., Goker H., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.99, sa.11, ss.1243-1246, 2007 (SCI-Expanded, Scopus)

61. Renin-angiotensin system expression in the K562 human erythroleukaemic cell line

Koca E., Haznedaroglu I. C., Acar K., Beyazit Y., Aksu S., Misirlioglu M., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.8, sa.3, ss.145-147, 2007 (SCI-Expanded, Scopus)

62. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia

Koca E., Sevimli F., Cetiner D., Haznedaroglu I. C., Sayinalp N., Buyukasik Y., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.82, sa.4, ss.333, 2007 (SCI-Expanded, Scopus)

63. Stenotrophomonas maltophilia infection of the central venous catheter and lysis of an old thrombosis in a post-bone marrow transplantation child: Implications in the fibrinolytic process

Uckan D., Kirazli S., Gur D., Tavil B., Sayinalp N., Akyuz C.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , cilt.39, sa.4, ss.376-379, 2007 (SCI-Expanded, Scopus)

64. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia

Beyazit Y., Aksu S., Haznedaroglu I. C., Kekilli M., Misirlioglu M., Tuncer S., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.99, sa.1, ss.57-63, 2007 (SCI-Expanded, Scopus)

65. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML

Aksu S., Beyazit Y., Haznedaroglu I. C., Canpinar H., Kekilli M., ÜNER A., et al.

LEUKEMIA & LYMPHOMA , cilt.47, sa.5, ss.891-896, 2006 (SCI-Expanded, Scopus)

66. Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation

Aksu S., Beyazit Y., Haznedaroglu I., Goker H., Kekilli M., Karakaya J., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.17, sa.1, ss.47-51, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Enhanced expression of the local haematopoietic bone marrow renin-angiotensin system in polycythemia Rubra vera

Aksu S., Beyazit Y., Hazneidaroglu I., Kekilli M., Canpinar H., Misirlioglu M., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.33, sa.6, ss.661-667, 2005 (SCI-Expanded, Scopus)

68. Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease

Cemalettin M., Aksoy D., Haznedaroglu I., Sayinalp N., Kirazli S., Alpaslan M.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.22, sa.5, ss.391-399, 2005 (SCI-Expanded, Scopus)

72. The predictability of factor V Leiden (FV : Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance

Sayinalp N., Haznedaroglu I., Aksu S., Buyukasik Y., Goker H., Parlak H., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.10, sa.3, ss.265-270, 2004 (SCI-Expanded, Scopus)

79. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behcet's disease: evidence of a prethrombotic state

Ozatli D., Sayinalp N., Buyukasik Y., Karakus S., Haznedaroglu I., Kirazli S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.21, sa.4, ss.137-140, 2002 (SCI-Expanded, Scopus)

80. Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis

Gurgey A., Haznedaroglu I., Egesel T., Buyukasik Y., Ozcebe O., Sayinalp N., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.67, sa.2, ss.107-111, 2001 (SCI-Expanded, Scopus)

87. Effects of interferon-alpha 2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha 2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behcet's disease

Kosar A., Haznedaroglu S., Karaaslan Y., Buyukasik Y., Haznedaroglu I., Ozath D., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.19, ss.11-14, 1999 (SCI-Expanded, Scopus)

93. Penile gangrene in lung cancer - Bronchiolo-alveolar carcinoma, disseminated intravascular coagulation, and nonbacterial thrombotic endocarditis.

Buyukasik Y., Sayinalp N., Arici M., Haznedaroglu I., Ozcebe O., Dundar S.

POSTGRADUATE MEDICAL JOURNAL , cilt.73, sa.863, ss.589-590, 1997 (SCI-Expanded, Scopus)

97. Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity

Gursoy M., Haznedaroglu I., Celik İ., Sayinalp N., Ozcebe O., Dundar S.

ANNALS OF PHARMACOTHERAPY , cilt.30, ss.762-765, 1996 (SCI-Expanded, Scopus)

104. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis

Sayinalp N., Erdem Y., Haznedaroglu I., Dundar S., Caglar S., Kirazli S.

CLINICAL NEPHROLOGY , cilt.44, sa.6, ss.404, 1995 (SCI-Expanded, Scopus)

105. BLOOD COLLECTION IN STRONG ACIDIC CITRATE ANTICOAGULANT FOR THE DETERMINATION OF UROKINASE-LIKE PLASMINOGEN ACTIVATOR

OZDEMIR O., HAZNEDAROGLU I., SAYINALP N., OZCEBE O., DUNDAR S., KIRAZLI S.

THROMBOSIS RESEARCH , cilt.80, sa.2, ss.189-191, 1995 (SCI-Expanded, Scopus)

106. MEGAKARYOCYTOPOIETIC CYTOKINES IN AUTOIMMUNE THROMBOCYTOPENIC PURPURA

HAZNEDAROGLU I., SAYINALP N., OZCEBE O., OZDEMIR O., DUNDAR S., KIRAZLI S.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.49, sa.3, ss.265, 1995 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim